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Simple Summary: Wild California sea lions (Zalophus californianus) have a high prevalence of uro-
genital carcinoma. The cancer starts in the sea lion’s genital tract then spreads aggressively to other 
organs resulting in death. Previous research has identified a herpesvirus, otarine herpesvirus 1 
(OtHV1), in the genital tract of most sea lions with urogenital carcinoma, however, this virus has 
also been found in the genital tracts of sea lions without cancer making its role in urogenital carci-
noma ambiguous. Here, tissues from 95 sea lions with and 163 without cancer were tested for 
OtHV1, the amount of virus was quantified, and viral gene expression was measured. OtHV1 was 
found in 100% of the sea lions with urogenital carcinoma and there were exceptionally high viral 
loads and viral gene expression within the genital tumors. Of the sea lions that did not have cancer, 
36% tested positive for herpesvirus and they had much lower viral load and no detectable viral gene 
expression, indicating the herpesvirus was dormant. These findings support that genital herpesvi-
rus plays an integral role in sea lion urogenital carcinoma and suggests there is an underlying trig-
ger or event that causes the virus to induce cancer in some infected sea lions and not others.  
Abstract: Urogenital carcinoma in California sea lions (Zalophus californianus) is the most common 
cancer of marine mammals. Primary tumors occur in the cervix, vagina, penis, or prepuce and ag-
gressively metastasize resulting in death. This cancer has been strongly associated with a sexually 
transmitted herpesvirus, otarine herpesvirus 1 (OtHV1), but the virus has been detected in genital 
tracts of sea lions without cancer and a causative link has not been established. To determine if 
OtHV1 has a role in causing urogenital carcinoma we sequenced the viral genome, quantified viral 
load from cervical tissue from sea lions with (n = 95) and without (n = 163) urogenital carcinoma, 
and measured viral mRNA expression using in situ mRNA hybridization (Basescope®) to quantify 
and identify the location of OtHV1 mRNA expression. Of the 95 sea lions diagnosed with urogenital 
carcinoma, 100% were qPCR positive for OtHV1, and 36% of the sea lions with a normal cervix were 
positive for the virus. The non-cancer OtHV1 positive cases had significantly lower viral loads in 
their cervix compared to the cervices from sea lions with urogenital carcinoma. The OtHV1 genome 
had several genes similar to the known oncogenes, and RNA in situ hybridization demonstrated 
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high OtHV1 mRNA expression within the carcinoma lesions but not in normal cervical epithelium. 
The high viral loads, high mRNA expression of OtHV1 in the cervical tumors, and the presence of 
suspected OtHV1 oncogenes support the hypothesis that OtHV1 plays a significant role in the de-
velopment of sea lion urogenital carcinoma. 
Keywords: California sea lion; cancer; urogenital carcinoma; herpesvirus; oncogenic virus; RNA in 
situ hybridization; Basescope® 
 
1. Introduction 
Wild California sea lions (Zalophus californianus) have the highest prevalence of can-
cer among the marine mammal species [1,2]. Over the last three decades, postmortem ex-
aminations of adult sea lions that stranded along the central and northern coastline of 
California, USA concluded that approximately one in four had cancer [1–3]. The vast ma-
jority (>90%) of these cancers were of the same type, urogenital carcinoma [2]. This cancer 
originates in the genital tract (cervix, vagina, penis, or prepuce) and aggressively spreads 
to the draining lymph nodes, liver, lungs, spleen, and/or kidneys, resulting in death 
[1,2,4,5]. There have been several studies of the etiology of this urogenital carcinoma, but 
much remains uncertain about its cause. 
Even in well-studied species, like humans or domestic animals, identifying the etiol-
ogy and cofactors contributing to the development of cancer is difficult. This is especially 
true in wild animals with limited accessibility and clinical history. This is because most 
cancers result from a multistep process and can involve several contributing factors in the 
progression of cellular transformation to malignancy. These can include a combination of 
immune suppression, genetic predisposition, toxin exposure, and/or infectious agents in 
addition to random accumulation of genetic mutations [6]. 
In previous studies, some of these potential cofactors have been epidemiologically 
associated with California sea lion urogenital carcinoma. For example: legacy contami-
nants including polychlorinated biphenyls (PCBs) and dichlorodiphenyltrichloroethane 
(DDT) are eight and six times higher, respectively, in blubber of sea lions with urogenital 
carcinoma [7,8]; sea lions with cancer were found to be more inbred than those dying from 
other causes and are more likely to be of certain genotypes [9,10]; and a herpesvirus infec-
tion, initially named California sea lion herpesvirus (GenBank accession # AF193617.1) 
and more recently referred to as otarine herpesvirus 1 (OtHV1), has been detected more 
often in the genital tract of sea lions with urogenital carcinoma than in those without this 
cancer [4,5,11,12]. Here we look further into the viral component of this cancer to deter-
mine if OtHV1 plays an integral role in the pathogenesis of urogenital carcinoma, or if it 
is an incidental finding of a virus with high penetrance in this population. 
Viral infections contribute to the development of 15 to 20% of cancers in humans [13–
15]. Viruses that have the potential to cause cancer are known as oncogenic viruses and 
include both RNA (Retroviridae and Flaviviridae) and DNA virus families (Herpesviri-
dae, Papillomaviridae, Hepadnaviridae, Adenoviridae, Poxviridae, and Polyomaviridae) 
[13,15–19]. Oncogenic viruses associated with malignancies in humans include: human 
gammaherpesvirus 4 (HHV4, aka Epstein-Barr virus) associated with Burkitt lymphoma, 
Hodgkin’s disease, nasopharyngeal carcinoma, gastric adenocarcinomas, and post-trans-
plant lymphomas; human gammaherpesvirus 8 (HHV8, aka Kaposi’s sarcoma-associated 
herpesvirus) associated with Kaposi’s sarcoma, multicentric Castleman’s disease, and pri-
mary effusive lymphoma; human papillomaviruses (HPV) associated with cervical can-
cer, anogenital cancer, skin cancer, and head and neck cancers; hepatitis B and C associ-
ated with hepatocellular carcinoma; and human T-lymphotropic virus 1 (HTLV-1) associ-
ated with the adult T-cell leukemia. In non-human species, similar oncogenic viruses are 
associated with neoplasms, documented in a wide range of species from primates to chick-
ens and frogs [18,20,21]. Across the viral families and in different host species, the host 
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cellular pathways targeted by oncogenic viruses are often analogous [19,22]. These highly 
conserved cellular pathways control fundamental processes including cellular prolifera-
tion, apoptosis, immune modulation, epigenetic modifications, and signal transduction 
pathways [23]. In the case of oncogenic viruses, this manipulation often results in in-
creased cellular and viral replication, interference with apoptotic pathways, and enables 
virally infected cells to evade immune surveillance—all pushing the cell down a path of 
malignancy [6,16,19]. 
Often the progression from viral infection to virally induced cancer is associated with 
cofactors that contribute to whether or not an infected cell becomes neoplastic. For exam-
ple, in humans close to 100% of adults carry one or more of eight types of endemic human 
herpesviruses [15,24–26]. Two of these, human HHV4 and HHV8, are known to induce 
cancers, but this malignant transformation only occurs in a very small subset of infected 
people [19,27–29]. This neoplastic transformation is often attributed to cofactors such as 
immunosuppression or toxin exposure [29–31]. For example, AIDS patients with human 
herpesvirus 8 (HHV8) infection are 500 times more likely to develop Kaposi’s sarcoma 
compared to the general population [29]. The high penetrance of these viruses combined 
with the influences of various cofactors make it challenging to establish a causal relation-
ship between a viral infection and the development of cancer when only assessing the 
infection status. 
After initial infection, herpesviruses typically become latent in their endemic host 
and rarely cause significant clinical disease [32]. However, viral recrudescence or latent 
herpesvirus proteins can induce disease in a subset of infected individuals, often associ-
ated with the cofactors above. Expression patterns of key viral genes (viral oncogenes) 
and non-coding RNAs have been implicated in determining whether a herpesvirus re-
mains latent, benign, and subclinical, or results in cellular transformation sending the host 
cell down a path of malignancy. Thus, in addition to determining if a host is infected with 
an oncogenic virus, it is imperative to assess the latent/lytic state of the virus and the pat-
tern of viral oncogene expression when trying to determine if a virus is responsible for 
inducing cancer. 
Because of ethical concerns and federal laws protecting the marine mammals in the 
USA, proving Koch’s postulates to determine the role of OtHV1 in sea lion carcinoma by 
infecting sea lions with OtHV1, observing the development of this cancer, and re-isolating 
the virus from tumor tissue is not feasible. Instead, molecular techniques and epidemio-
logic approaches must be used [33,34]. Here, we tested sea lion cervix for OtHV1 infection, 
then measured the viral loads using quantitative PCR (qPCR) to determine if the virus 
was dormant or actively being expressed in infected individuals. Infection status and viral 
loads were then compared between cancer and non-cancer cases. Next, a draft genome of 
OtHV1 was assembled and annotated. OtHV1 genes were compared to known oncogenic 
herpesviruses to identify the potential viral oncogenes in OtHV1. Last, RNA in situ hy-
bridization (RISH) probes were designed to visualize the OtHV1 mRNA expression 
within urogenital carcinoma lesions as well as in normal cervix in sea lions that tested 
positive for the virus. By assessing these parameters in sea lions with and without uro-
genital carcinoma, we can determine whether OtHV1 plays a significant role in the path-
ogenesis of urogenital carcinoma or is simply an incidental finding. 
2. Materials and Methods 
2.1. Sample Collection 
California sea lions in this study stranded along the central and northern California 
coast from 2002 to 2017 and were admitted to The Marine Mammal Center in Sausalito, 
CA, USA for medical care (Marine Mammal Protection Act permit number 18786). Be-
cause of the advanced disease, the sea lions in this study died naturally while undergoing 
treatment or were humanely euthanized. All sea lions included in this study were adult 
females. Complete necropsy and histologic evaluation were performed to establish the 
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cause of death, determine the presence/absence of urogenital carcinoma, and cervix sam-
ples were collected and frozen (−80 °C) for OtHV1 molecular analysis [35]. 
Samples of normal cervix or cervical tumors when grossly discernable were collected. 
Cervix samples were fixed in 10% neutral buffered formalin (NBF), embedded in paraffin, 
sectioned at 5-µm thickness, stained with hematoxylin and eosin (H&E), and evaluated 
by a pathologist with expertise in sea lion urogenital carcinoma. Each case was classified 
as urogenital carcinoma (cancer cases) or non-urogenital carcinoma (control cases) based 
on histologic evaluation as previously described [36,37]. Briefly, sea lions were classified 
as control cases if there was normal cervical epithelium composed of pseudostratified co-
lumnar epithelium and no evidence of urogenital carcinoma on gross or histological eval-
uation (Figure S1) [37]. Sea lions with urogenital carcinoma had evidence of moderate to 
markedly dysplastic cervical epithelium with atypical parabasal cell proliferation extend-
ing from one-third to the entire thickness of the epithelium (Figure S2) and/or invasive 
cervical lesions (Figure S3) with or without evidence of metastasis were classified as can-
cer cases. 
The cervix samples used for RNA in situ hybridization (n = 25) were collected be-
tween 5 minutes and 24 hours postmortem and immediately fixed in 10% NBF for no more 
than 36 hours (n = 11) or frozen (−80 °C) then fixed in 10% NBF for 24 hours (n = 14) before 
being processed as described above. On histologic evaluation, lesions in this subset of 
cases were further classified into either cervical intraepithelial lesions (CIN) (Figure S2) or 
invasive lesions (Figure S3) [36] which approximate those in an established grading scale 
used in human cervical and vaginal neoplasms [38]. 
A second cervical tissue sample from the same area sampled above was frozen (−80 
°C) until processed for OtHV1 qPCR analysis and OtHV1 genomic sequencing. Illumina 
MiSeq, Pacific Biosciences (PacBio) single molecule real time (SMRT), and Sanger sequenc-
ing platforms were used to obtain the OtHV1 genome from the cervical tumor DNA ex-
tract (described below). The entire MiSeq and PacBio runs were dedicated to total DNA 
extracted from this single tumor sample to minimize the herpesvirus strain variability. 
Otarine herpesvirus 4 (OtHV4), a closely related herpesvirus identified in the genital 
tract of northern fur seals, was also sequenced and compared to OtHV1. Urogenital carci-
noma has not been documented in the northern fur seals, and to date, no disease progres-
sion has been identified in association with OtHV4 infection [39]. For OtHV4 genome se-
quencing, a vaginal swab collected from a northern fur seal (Callorhinus ursinus) on the 
Pribilof Islands, Alaska, USA (Marine Mammal Protection Act permit number 932-
1905iMA-009526), previously identified to be positive for OtHV4 with a high viral load, 
was used [39]. This was a wild fur seal sampled during routine health assessments of the 
population and was determined to be healthy. 
2.2. PCR and qPCR 
DNA was isolated from all California sea lion cervix biopsies using a Qiagen kit ac-
cording to the manufacturer’s instructions (DNeasy Blood and Tissue, Qiagen Inc., Valen-
cia, California, USA). For the northern fur seal vaginal swab, DNA was isolated using a 
Maxwell automated extractor and Maxwell 16 Buccal Swab Purification kit according to 
the manufacturer’s instructions (Promega, Madison, Wisconsin, USA). PCR, qPCR, and/or 
viral genome sequencing was performed immediately, or DNA extracts were stored at 
−80 °C pending analysis. 
For OtHV1, novel PCR and qPCR primers and probe were designed (Table 1) to tar-
get unique areas of the OtHV1 DNA-dependent DNA polymerase gene with Black Hole 
Quencher probe and FAM reporter dye and validation, sensitivity and specificity of these 
primer sets were performed (Supplemental Material Methods S1). DNA extracts from Cal-
ifornia sea lion cervix samples (n = 258) were screened for OtHV1 using a 7500 Fast Real-
Time PCR System (Applied Biosystems) with OtHV1-specific qPCR primers, probe, and 
conditions described in the supplemental material (Methods S1). 
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To determine if there was a difference between the proportion of sea lions in the can-
cer and control groups that were infected with OtHV1, a binomial ANOVA was used. 
Additionally, descriptive statistics, quartile values, and a Mann–Whitney test were used 
to determine if there were higher viral loads (copies/ng DNA) in cervical tissue with uro-
genital carcinoma compared to the normal cervix that was positive for OtHV1. Lastly, a 
binomial general linear model was used to determine the difference in OtHV1 abundance 
(viral load) between cancer cases and non-cancer cases. Goodness of fit was assessed and 
there were no outliers identified. 
Table 1. PCR and qPCR primers and probes used for OtHV1 and OtHV4 qPCR screening. 
Primer/Probe Name Primers (5′-3′) Reference 
OtGHV1_polF CTTCGCATGGGTGGACTACT This Study 
OtGHV1_polR TCATGCCTACTAGCAGCAGC This Study 
OtGHV1qPCRF TCCCACGCTGTTTCGAATG This Study 
OtGHV1qPCRR AGCTCCGAGTCGTGTACACAGTAT This Study 
OtGHV1_Probe TCGCGCTCGCATCGGCA This Study 
OtGHV4F2 TCCACAATGATACTGGATGAAGA Cortés-Hinojosa et al., 2016 
OtGHV4R4 CTAGAATTGCACGACGCTGT Cortés-Hinojosa et al., 2016 
QPCR_OtGHV4F2 CTTCAACATTAGCTCCGGATT Cortés-Hinojosa et al., 2016 




Cortés-Hinojosa et al., 2016 
2.3. Viral Genome Sequencing 
One California sea lion cervical tumor, with a high viral load on qPCR results, was 
selected for OtHV1 genome sequencing. This sample was PCR and qPCR negative for 
OtHV4 and positive for OtHV1, with approximately 1.7 × 107 viral copies detected per 
nanogram of DNA. One northern fur seal vaginal swab was selected for OtHV4 genome 
sequencing. This sample was PCR and qPCR negative for OtHV1 and positive for OtHV4, 
with a viral load indicated by qPCR of approximately 3.44 × 105 viral copies detected per 
nanogram of DNA. 
Illumina MiSeq, Pacific Biosciences (PacBio) single molecule real time (SMRT) and 
Sanger sequencing platforms were used to obtain the OtHV1 genome from the cervical 
tumor DNA extract. The entire MiSeq and PacBio runs were dedicated to total DNA ex-
tracted from this single tumor sample to minimize the herpesvirus strain variability and 
facilitate viral genome assembly. 
The DNA library for OtHV1 was constructed using a Nextera XT sample preparation 
kit as directed by the manufacturer (Illumina). The library was quantified using a Qubit 
2.0 spectrophotometer (Life Technologies, Carlsbad, CA, USA) and analyzed for size dis-
tribution using a Bioanalyzer (Agilent). Sequencing was performed on an Illumina MiSeq 
with 2 × 300-nt paired-end reads following standard Illumina protocols. Preliminary bio-
informatics analysis (see methods below) produced a ~150 Kbp draft genome for OtHV1 
composed of three large non-overlapping contiguous sequences (contigs). Further at-
tempts to bridge the gaps in the MiSeq generated OtHV1 contigs were performed using 
PacBio SMRT and conventional PCR as described in the Supplemental Materials (Methods 
S2). 
Next, Illumina MiSeq and Sanger sequencing platforms were used to sequence the 
OtHV4 genome from total DNA extracted from a northern fur seal vaginal swab. For the 
MiSeq run, a DNA library was constructed using Nextera XT sample preparation kit as 
directed by the manufacturer (Illumina). The library was quantified using a Qubit 2.0 
spectrophotometer (Life Technologies, Carlsbad, CA, USA) and analyzed for size distri-
bution using a Bioanalyzer (Agilent). The library was then sequenced on an Illumina 
MiSeq with 2 × 300-nt paired-end reads following standard Illumina protocols. Additional 
OtHV4 gap closure was attempted using novel primers (design based on generated draft 
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OtHV4 genome) for conventional PCR using platinum Taq DNA polymerase (Invitrogen, 
Carlsbad, CA, USA), GC RICH PCR System (Sigma-Aldrich, Atlanta, GA, USA), and 
TaKaRa Ex Taq® Hot Start Version (Takara Bio, Mountain View, CA, USA). 
Sequence data for both OtHV1 and OtHV4 MiSeq runs were stored on BaseSpace and 
transferred into CLC Genomics 9.5.3 for trimming, genome assembly, and annotation. To 
generate the OtHV1 genome, a de novo assembly was performed on trimmed reads using 
CLC Genomics with default settings. Contigs larger than 2 Kbp were selected and a 
BLAST search for similarity with known herpesviruses in the nucleotide collection (nr/nt) 
database was performed to identify the viral contigs from sea lion genomic DNA. OtHV1 
contigs were ordered for display purposes similar to HHV8 (GenBank number: 
NC_009333.1). The PacBio reads were then assembled using the MiSeq OtHV1 draft ge-
nome (three large contigs) as scaffolding in an attempt to fill the gaps and confirm the 
MiSeq-generated OtHV1 draft genome assembly. For OtHV4, de novo assembly was per-
formed using the same method described above. In addition, the northern fur seal MiSeq 
paired-end reads were assembled using the OtHV1 draft genome as a scaffold. 
To predict putative protein coding genes, open reading frames (ORFs) with a start 
codon of AUG that were larger than 150aa were identified using CLC Genomics. Addi-
tional ORFs larger than 100aa were also explored, but only included when associated with 
an E-value of <0.01 on a BLASTP search. These ORFs were then searched against the pfam 
database and Genome Annotation Transfer Utility (GATU, http://athena.bioc.uvic.ca/vi-
rology-ca-tools/gatu/) and named according to their associated homologues when availa-
ble. Additional ORFs were identified using BLAST searches, and a small number did not 
have a known function and/or predictable putative protein. These unidentified ORFs were 
annotated with a prefix of “Ot,” for Otarine, and a number that corresponded to its novel 
gene order starting at the 5-prime end of the genome. 
2.4. Viral Phylogenetic Analysis 
Predicted amino acid sequences of four herpesvirus core genes (polymerase, termi-
nase, glycoprotein B, and major capsid protein) from OtHV1, OtHV4, and twenty-seven 
herpesviruses representative of all known herpesvirus genera were used for viral phylo-
genetic analysis (Tables S1 and Tables S2). Homologous sequences were aligned using 
MAFFT (https://www.ebi.ac.uk/Tools/msa/mafft) [27]. Bayesian analyses of each align-
ment were conducted using Mr. Bayes 3.2.6 on the CIPRES server with mixed amino acid 
substitution models, gamma distributed rate variation, and a proportion of invariable 
sites [26, 28]. A total of four chains were run, and statistical convergence was assessed via 
the average standard deviation of split frequencies and potential scale reduction factors 
of the parameters. Human alphaherpesvirus 3 (GenBank Accession # NC_001348) was se-
lected as the outgroup for the core gene analyses. The initial 25% of 2,000,000 iterations 
were discarded as burn in. When no significant differences in topology were seen in the 
core gene analyses, the core gene alignments were concatenated, and the concatenated 
alignment was used for Bayesian analysis using the same methodology. 
Maximum Likelihood (ML) analyses of each alignment were performed using 
RAxML-HPC2 version 8.0.24 on the CIPRES server [29] with a gamma distributed rate 
variation and proportion of invariable sites. Human alphaherpesvirus 3 (GenBank Acces-
sion # NC_001348) was selected as the outgroup for the core gene analyses. Bootstrap 
analysis was used to test the strength of the tree topology; 1000 resamplings were per-
formed [30]. When no significant differences in topology were seen in the core gene anal-
yses, the core gene alignments were concatenated, and the concatenated alignment was 
used for maximum likelihood analysis using the same methodology. 
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2.5. RNA In Situ Hybridization 
To localize OtHV1 mRNA expression in urogenital carcinoma, five RISH probes 
(Basescope®, Advanced Cell Diagnostics Inc., Newark, CA, USA) were designed to specif-
ically bind to OtHV1 genes that were thought to have oncogenic potential, including 
vBCL2, vFLIP, vCDK4, vEVE, and EBNA1-like (Table S3). Additionally, a positive control 
designed to bind to sea lion housekeeping gene DNA-dependent RNA polymerase II 
(dpolR2A) and a negative control dihydrodipicolinate reductase (dapB) of Bacillus subtilis 
were used for quality control. To optimize specificity, we utilized the Basescope® platform 
to ensure the host-derived OtHV1 gene would not cross react with homologous host cel-
lular genes. 
Visualization of five OtHV1 gene transcripts was performed using custom 
Basescope® probes and BasescopeTM® Red Reagent Kit (Advanced Cell Diagnostics 
(ACD), Hayward, California, USA, cat #322910) following the manufacturer’s protocol 
with minor modification (Supplemental Materials Methods S3). Following IHC staining, 
each tissue section was imaged using CellSens Entry 1.11 software (Olympus) slide scan-
ner on an Olympus BX46 with a 40X objective (area in field of view = 0.34 mm2). Images 
were imported into ImageJ. Regions of interest were defined as normal epithelium in con-
trols or neoplastic epithelium in cancer cases. Using the ImageJ polygon tool (Supple-
mental Materials Methods S4), representative areas of normal cervix, CIN, and invasive 
urogenital carcinoma lesions were selected, avoiding regions of inflammation, necrosis, 
underlying stroma, or poor-quality staining—for instance, at the cut edge of the sections. 
The software quantified the area of the positive hybridization signal (representing any 
positive stained pink dot) as well as the unstained area in the region selected. The total 
positive hybridization signal area was divided by the total area of interest and defined as 
the percent positive hybridization signal. 
The percent positive hybridization was compared between healthy, CIN, and inva-
sive samples for all RISH probes as well as the positive and negative controls. Descriptive 
tables (quartiles) were generated from the percent positive hybridization signal to deter-
mine the extent of probe binding for healthy, CIN, and invasive samples. To compare the 
proportion of positive hybridization signal in non-cancer animals to CIN and invasive 
lesions in cancer animals, a generalized linear mixed model with a binomial distribution 
and a log-odds (logit) link function was used, as data were not normally distributed. A 
Tukey test was used to investigate the differences between groups (Healthy, CIN, and 
Infiltrative) in order to determine the significance, with a p-value of <0.01. Descriptive 
statistics (minimum, first quartile, median, second quartile, and maximum) for percent 
positive hybridization signal were generated for all OtHV1 probes, as well as negative 
and positive probe controls. 
3. Results 
3.1. Histologic Determination of Urogenital Carcinoma and Control Cases 
From 2002 to 2017, cervix samples were collected at necropsy from 258 sea lions. His-
tologic evaluation showed 63% (n = 163) of the sea lions had normal cervical epithelium 
with no evidence of urogenital carcinoma and 37% (n = 95) had urogenital carcinoma (Ta-
ble S4 and S5). Within the subset of cases used for RNA in situ hybridization (n = 25), 9 
had a normal cervix and 16 had carcinoma. The cervical lesions of the carcinoma cases 
were further classified histologically as CIN (n = 7) or invasive (n = 9) lesions (Table S5). 
3.2. PCR and qPCR 
3.2.1. OtHV1 PCR and qPCR Validation 
All 10 samples from known OtHV1 positive California sea lion cervical tumors were 
positive with the novel OtHV1-specific PCR and qPCR primers confirmed to be OtHV1 
with Sanger sequencing; 10 OtHV1 negative California sea lion cervix samples were all 
negative; and all non-OtHV1 herpesvirus positive samples (OtHV4, OtHV3, and sea turtle 
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herpesvirus) were negative using the novel OtHV1-specific PCR and qPCR primer sets. 
To confirm the lack of cross reactivity between OtHV1 and OtHV4, all above mentioned 
samples were also tested for OtHV4 using PCR and qPCR with previously published pri-
mers, probe, and conditions [39]. All samples tested negative for OtHV4 except the four 
known OtHV4 positive vaginal swabs from the northern fur seals. 
3.2.2. OtHV1 qPCR Testing and Viral Quantification 
Frozen subsections of the cervix were used for viral quantification (viral copies per 
nanogram of DNA on qPCR) in control versus cancer samples (cervix and cervical lesions, 
respectively). All cervical samples (control = 163; cancer = 95) were tested using the 
OtHV1-specific qPCR. OtHV1 was detected in 100% (95/95) of cancer cases compared to 
36% (59/163) of control cases. The proportion of cancer cases that were positive for OtHV1 
was significantly different (p < 0.0001) from the number of control cases that were positive 
for OtHV1. 
Viral load of OtHV1 positive control (n = 59) and cancer (n = 95) cases were compared 
(Table S6). In normal cervix that was OtHV1 positive the median viral load was 11,551, 
and in urogenital carcinoma cases the median viral load was 6,704,760 (Table S6). Viral 
loads in control and cancer cases were not normally distributed, and non-parametric anal-
ysis was used to determine the significance. The Mann–Whitney test showed an extremely 
statistically significant difference (p < 0.0001) in viral load between the control group (n = 
59, median = 11,551 copies/ng DNA) and cancer group (n = 95, median = 6,704,760 cop-
ies/ng DNA) (Figure 1A; Table S6). This proved the viral load was significantly lower in 
the cervical tissue of controls that were qPCR positive for OtHV1 compared to the viral 
load in sea lion cervix with urogenital carcinoma. 
Using these OtHV1 viral loads produced from qPCR on cervix, a binomial general 
linear model of the probability of having cancer based on the abundance of OtHV1 (viral 
copies/ng DNA) showed that higher viral loads increase the probability of having urogen-
ital carcinoma in OtHV1 positive cervical biopsies (Figure 1B). This model can be used to 
interpret the significance of an OtHV1 positive cervical biopsy by predicting the probabil-
ity of having cancer given the abundance of the virus (viral copies/ng DNA) in an animal 
with unknown cancer status. By screening the cervical biopsies for urogenital carcinoma 
with OtHV1 qPCR in addition to the histologic evaluation, clinicians can use this model 
to predict the probability of an OtHV1-positive sea lion to have cancer based on OtHV1 
viral load.  






Figure 1. The above graphs show OtHV1 qPCR results from California sea lion cancer and control 
cases that were qPCR positive for OtHV1. (a) Box plot representing OtHV1 viral copies per nano-
gram of DNA detected (copies/ng DNA) determined by OtHV1 qPCR, including all OtHV1 posi-
tive histologically normal cervix (control; n = 59) and urogenital carcinoma (cancer; n = 95) cases. * 
= significantly different (p < 0.0001). (b) Binomial general linear model of the probability of having 
cancer based on the abundance of OtHV1 (log of number of viral copies detected per nanogram of 
DNA in the reaction) quantified with OtHV1-specific qPCR. Non-cancer cases are on 0.0 and can-
cer case are on the 1.0 lines. 
3.3. OtHV1 and OtHV4 Sequencing and Annotation 
To further understand the role of OtHV1 in urogenital carcinoma, its genome was 
sequenced, annotated, and evaluated to identify the potential viral oncogenes. De novo 
assembly of the Illumina MiSeq data generated an OtHV1 draft genome consisting of three 
non-overlapping herpesvirus contigs. Neither the PacBio SMRT nor conventional PCR 
bridged the gaps between the three OtHV1 contigs generated by the MiSeq run de novo 
assembly, and these contigs could not be joined with bioinformatic manipulation or walk-
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Kbp contig ranging from the 5’ end to ORF11 (Contig1: MN334559), a 93 Kbp contig rang-
ing from ORF17 to ORF69 (Contig2: MN334560), and a 17 Kbp contig ranging from ORF75 
to the 3’end (Contig3: MN334561) (Figure S4B). For display purposes, contigs were or-
dered similar to HHV8 (GenBank number: NC_009333.1) (Figure S4A). 
A related pinniped herpesvirus, OtHV4, was also sequenced from a northern fur seal 
vaginal swab for comparison. This sample had much lower OtHV4 viral loads, and the 
majority of sequence obtained was host genome. Similar viral genome sequencing and 
assembly limitations were seen with OtHV4 that occurred with the OtHV1 genome. There 
were three gaps in the OtHV4 genome, resulting in four non-overlapping contigs (Gen-
Bank numbers: Contig1 = MN545486, Contig2 = MN545487, Contig3 = MN545488, Contig4 
= MN545489) (Figure S4C). The gene order of OtHV4 was similar to OtHV1 and HHV8 
and the contigs were ordered similarly for display purposes. Two of the gaps in OtHV4 
were in the same areas as the gaps in OtHV1 (between ORF11 and ORF 17; and between 
ORF 69 and ORF 75). In HHV8, these areas of the genome have high GC content and tan-
dem repeats, which may explain the difficulty sequencing and assembling these areas in 
OtHV1. This is compounded by the high concentration of host DNA in the samples during 
sequencing. Additionally, viral integration into the host genome cannot be ruled out and 
may contribute to the difficulty closing the OtHV1 and OtHV4 genomes when employing 
these sequencing and assembly techniques. 
Annotation of the OtHV1 genome identified several genes similar to known gam-
maherpesvirus oncogenes, including Epstein-Barr Nuclear Antigen 1 (EBNA1), viral Fas-
associated death domain-like interleukin-1β-converting enzyme-inhibitory protein 
(vFLIP), viral B-cell lymphoma 2 (vBCL2), viral cyclin-dependent kinase 4 (vCDK4), and 
a suspected endogenous viral elements (vEVE). In human herpesvirus-infected cells, 
EBNA1 and vFLIP are viral promoters and influence the host cellular pathways involved 
in cell proliferation including apoptosis, immune modulation, epigenetic modification, 
and signal transduction pathways [23,40]. vBCL2 interferes with apoptotic pathways and 
blocks autophagy, which in turn helps virally infected cells evade immune surveillance 
[41]. Viral cyclins are transcriptional regulators that help initiate host cell cycling [42]. 
Lastly, EVEs are viral elements inserted into either host and viral genomes that are 
thought to be derived from retroviruses, and in some instances have been associated with 
malignancies [15]. Transcription of these potential oncogenes in California sea lion uro-
genital carcinoma and normal cervical epithelium were further investigated using RISH. 
3.4. Phylogenetic Analysis 
Concatenated Bayesian and maximum likelihood phylogenetic analyses using four 
herpesvirus core genes (polymerase, terminase, glycoprotein B, and major capsid protein) 
from a diverse representation of herpesviruses (Table S1 and S2) were performed. There 
was an early branching of the otarine herpesviruses (OtHV1 and OtHV4) within the gam-
maherpesvirus subfamily, divergent to a degree consistent with a new genus of herpesvi-
ruses that includes OtHV1 and OtHV4 and a herpesvirus sequenced from a proliferative 
lesion on the genital epithelium of a wild common bottlenose dolphin (Delphinid gam-
maherpesvirus 1; GenBank number: NC_035117.1) [43]. It appears that this clade branched 
from other gammaherpesviruses early in the subfamily’s evolution; the lack of terrestrial 
mammal representatives to date is interesting (Figure 2). A taxonomic proposal has been 
submitted to the International Committee on Taxonomy of Viruses supporting the classi-
fication of these viruses into a new genus within the family Herpesviridae (TaxoProp 
Marmaherpesvirus). 
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Figure 2. Bayesian analysis phylogram based on 4 concatenated herpesvirus core genes (polymerase, terminase, glycopro-
tein B, and major capsid protein) using predicted amino acid sequences. Bayesian posterior probabilities of each branch 
are expressed as % (top) and maximum likelihood (ML) bootstrap values as % (bottom). Asterisks (*) indicate 100%/100% 
values. Branch color is based on grouping herpesvirus subfamilies (yellow-Alphaherpesvirinae, blue-Betaherpesvirinae) 
and genera (green-lymphocryptoviruses, maroon-macaviruses, pink-percaviruses, orange-rhadinoviruses, and red- pro-
posed genus Marmamvirus). Otarine HV1, Otarine HV4 and Delphinid GHV1 branch form a clade distinct from other 
known gammaherpesvirus genera. 
3.5. OtHV1 mRNA Expression in Urogenital Carcinoma and Control Cases 
The 16 cases with urogenital carcinoma (CIN and invasive) had significantly higher 
(p < 2 × 10−16) OtHV1 RISH binding for the five OtHV1 probes (EBNA1, vFLIP, vBCL2, 
vCDK4, and vEVE) compared to the control cervix (Figure 3). Positive hybridization sig-
nals of OtHV1 RISH probes were localized to the nucleus and to a lesser extent within the 
cytoplasm of the neoplastic epithelial cells. Quartile results for percent positive hybridi-
zation signal for all OtHV1 RISH (Basescope®) probes, positive and negative controls can 
be found in Supplemental Materials for control cases (Table S7), CIN (Table S8), and in-
vasive lesions (Table S9). All control and cancer cases had no binding with the negative 
control RISH probe (dpol). There was no significant difference in polR2A hybridization 
signal among the healthy, CIN, or invasive lesions; thus, this cellular housekeeping posi-
tive control is an appropriate positive control for California sea lions with and without 
urogenital carcinoma. 
Most animals with urogenital carcinoma had diffuse lesions throughout the section 
of cervix sampled, with no normal epithelium. These cases had strong, evenly distributed, 
positive hybridization signal throughout the neoplastic tissue. However, one cancer case 
with both normal and neoplastic cervix within the examined sections had positive hybrid-
ization signal for all OtHV1 probes only in the neoplastic lesion and not in the surround-
ing normal epithelium (Figure 4). The positive control (pol2A) was evenly distributed 
throughout the normal and neoplastic epithelium. 


























    Healthy Controls            CIN                Invasive         
 
Figure 3. Series of H&E (Row 1: A, B, C) and RISH (Basescope®) labeled tissue (Rows 2 to 6: D through R), pink dots 
represent positive hybridization signaling. Rows 2, 3 and 4 are 3 OtHV1 RISH probes (Row 2- vBCL2, Row 3- vCDK4, 
Row 4-EBNA1). Row 5 is the positive control, California sea lion DNA-dependent RNA polymerase II (dpolR2A). Row 6 
is the negative control dihydrodipicolinate reductase (dapB) of Bacillus subtilis. Note that there is no positive hybridization 
signal of the OtHV1 probes in the normal cervix (D, G and J), and there is a large amount of positive hybridization signal-
ing in both the CIN (Column 2) and invasive (Column 3) lesions from cases with urogenital carcinoma. This shows that 
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there is high OtHV1 mRNA expression in both CIN and invasive cervical tumors, but not in normal cervical epithelium. 
There was no positive hybridization signal in the negative control (Row 6) for control, CIN or invasive lesions. 
 
Figure 4. Histology section of the edge of a urogenital carcinoma lesion in the cervix of a Califor-
nia sea lion with normal epithelium (left side of images) transitioning into cervical intraepithelial 
carcinoma (CIN; right side of images) with inflammation in the underlying submucosa. Series 
shows (A) H&E and (B–D) RISH (Basescope®) labeled tissue (B) OtHV1vEVE; (C) host housekeep-
ing gene DNA-dependent RNA polymerase II RISH positive control; (D) negative control dihy-
drodipicolinate reductase of Bacillus subtilis). On the RISH labeled tissues (B–D), pink dots repre-
sent positive hybridization signaling. 
4. Discussion 
Infectious agents are associated with over 20% of cancers [13] and here we add 
OtHV1 and California sea lion urogenital carcinoma to that list. In this study, 100% of sea 
lions with urogenital carcinoma were infected with OtHV1. In line with previous studies, 
however, over a third of sea lions with normal cervical epithelium were also positive for 
OtHV1, but these animals had exceptionally low viral loads in their cervical tissue (me-
dian = 11,551 viral copies/ng DNA) and there was no viral gene expression detected in the 
healthy cervical epithelium. These findings support that OtHV1 is in the latent state in 
these infected sea lions that do not have urogenital carcinoma, similar to latently infected 
people with HPV, HHV4, or HHV8 that never developed associated malignancies. 
This is in stark contrast with viral load and OtHV1 gene expression patterns in sea 
lions with urogenital carcinoma. Viral loads were very high in sea lions with urogenital 
carcinoma (median = 6,704,760 viral copies/ng DNA) and viral gene expression was sig-
nificantly higher in cervical tumors but not in underlying stroma or normal cervical epi-
thelium. This is profoundly apparent in the one case where both normal cervical epithe-
lium and carcinoma in situ were observed in the same section (Figure 4). The very high 
expression of all five OtHV1 genes tested within the invasive portion of the cervix but not 
in the neighboring normal-appearing cervical epithelium support the hypothesis that 
OtHV1 plays a critical role in sea lion urogenital carcinoma development. 
The model developed to predict a sea lion risk of having cancer based on the viral 
load provides a powerful clinical tool. With more than a third of the non-cancer sea lions 
(normal cervix) testing qPCR positive for OtHV1, this predictive model is a useful tool for 
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interrupting sea lions with positive OtHV1 results and can help clarify if a positive OtHV1 
result is a clinically significant finding indicative of cancer. 
Phylogenetic analysis of OtHV1 showed it is most closely related to the herpesvirus 
family, gammaherpesviruses- several of which are known to have oncogenic potential. 
There was, however, an early branching of two pinniped herpesvirus (OtHV1 and OtHV4) 
and a dolphin herpesvirus (DeGHV1 associated with benign genital tumors) from the 
gammaherpesvirus subfamily. This early divergence indicates these three herpesviruses 
compose a novel genus of herpesviruses. The lack of a herpesvirus from a terrestrial mam-
mal in the divergent clade may indicate that this group of herpesviruses co-evolved with 
marine mammals. In addition, there are several known viral oncogenes in HHV4 and 
HHV8 that alter signal transduction pathways, block apoptosis, and inactivate tumor sup-
pressor pathways which contribute to their oncogenic potential [42,44]. Similar genes 
were identified in OtHV1, and further research is needed to better understand the roles 
these genes have in driving the development of this cancer. 
Sea lions are top level coastal predators exposed to many of the same dietary con-
taminants and environmental stressors as humans. The now solidified link between 
OtHV1 and urogenital carcinoma in sea lions offers the opportunity to study naturally 
occurring herpesvirus-associated cancer in a novel species. This cancer can serve as a 
model for investigating viral/host interplay and give insight into basic cellular processes 
perturbed in these cancers in a naturally developing disease process. As in other virally 
induced cancers, there are likely several cofactors that contribute to the development of 
urogenital carcinoma. The oncogenic mechanisms employed by OtHV1 in urogenital car-
cinoma more realistically represent the pathophysiology of the virally induced cancer pro-
gression than traditional laboratory models because they are occurring in a natural host 
with an intact immune system and microenvironment representative of how this cancer 
develops under real-life conditions. Marine mammal rehabilitation centers along the west 
coast of the USA have access to these sick sea lions when they strand in end stage disease 
and euthanasia is the only humane option. Studying urogenital carcinoma in California 
sea lions can provide a valuable real-world model for virally induced cancer in a naturally 
occurring host [45]. 
5. Conclusions 
Our findings conclude that OtHV1 plays an integral role in the pathogenesis of uro-
genital carcinoma in California sea lions. The significantly high viral load and exception-
ally high viral gene expression within the cervical tumors in infected sea lions offer evi-
dence that this cancer is virally induced. The low viral load and lack of viral gene expres-
sion in infected sea lions with normal cervical epithelium further provide support that if 
the virus is in a latent state there is no apparent effect on the cervical epithelium. In addi-
tion, composition of an OtHV1 draft genome identified several viral genes that are similar 
to previously identified oncogenes in other cancer-associated viruses. We hypothesize 
that, similar to other virally induced cancers, there are necessary cofactor(s) or triggering 
event(s) that cause OtHV1 to transition from a latent state to an activated state starting 
from the cervical epithelium down a pathway of cellular transformation and malignancy. 
Supplementary Materials: The following are available online at www.mdpi.com/2076-
2615/11/2/491/s1: Methods S1: PCV and qPCR validation, Methods S2: PacBio and consensus PCR 
methods, Methods S3: RISH staining protocol, Methods S4: RISH quantification and analysis. Figure 
S1: H&E section of normal sea lion cervix. Figure S2: H&E section of urogenital carcinoma in sea 
lion cervix. Figure S3: H&E section of invasive urogenital carcinoma in sea lion cervix. Table S1: 
Herpesvirus species included in concatenated phylogenetic tree analysis. Table S2: Herpesvirus 
genes included in concatenated phylogenetic tree analysis. Table S3: Custom RISH probes. Table S4. 
Cervix histologic findings, OtHV1 qPCR results, and cause of death from California sea lions 
deemed controls used for RISH. Table S5: Cervix histologic findings, OtHV1 qPCR results, and cause 
of death from California sea lions deemed cancer cases used for RISH. Table S6: Quartile values of 
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qPCR viral loads (OtHV1) from normal cervix and cervix with urogenital carcinoma. Table S7: Quar-
tile values of OtHV1 RISH probes from sea lions with normal cervix. Table S8: Quartile values of 
OtHV1 RISH probes from sea lions with carcinoma intraepithelial neoplasia (carcinoma in situ) uro-
genital carcinoma. Table S9: Quartile values of OtHV1 RISH probes from sea lions invasion urogen-
ital carcinoma 
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